Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis

scientific article

Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.SEMARTHRIT.2010.05.008
P698PubMed publication ID20656330
P5875ResearchGate publication ID45287256

P50authorLoreto CarmonaQ56419499
Jesús MaeseQ57030705
David Díaz ValleQ57046315
P2093author name stringEsperanza Pato
Félix Francisco
Santiago Muñoz-Fernández
Ana Ortiz
Miguel A Abad
Uveitis Working Group from Spanish Society of Rheumatology
P433issue4
P921main subjectuveitisQ280027
immunosuppressionQ1455316
systematic reviewQ1504425
P304page(s)314-323
P577publication date2010-07-24
P1433published inSeminars in Arthritis and RheumatismQ15761553
P1476titleSystematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis
P478volume40

Reverse relations

cites work (P2860)
Q40300568A case of uveitis in adult-onset Still's disease with ophthalmologic symptoms
Q33939523Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center.
Q53767292Biomechanical evaluation of cornea in patients with ankylosing spondylitis.
Q40781984Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis
Q34957643Corneal Langerhans cell and dry eye examinations in ankylosing spondylitis.
Q37931096Cutting-edge issues in autoimmune uveitis
Q37709990Development of an activity disease score in patients with uveitis (UVEDAI).
Q35608168Efficacy of anti-tumor necrosis factor therapy for extra-articular manifestations in patients with ankylosing spondylitis: a meta-analysis
Q35699360Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients
Q36273801In Vitro and In Vivo Sustained Zero-Order Delivery of Rapamycin (Sirolimus) From a Biodegradable Intraocular Device
Q37215981Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis.
Q41109836Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery
Q35648227New insights in the clinical understanding of Behçet's disease.
Q36722548Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study
Q34274075Pharmacotherapy for uveitis: current management and emerging therapy
Q92072205Retinal vasculitis the first clue in the diagnosis of progressive hemifacial atrophy
Q42243489Systematic analysis of wide-field fundus autofluorescence (FAF) imaging in posterior uveitis
Q38074446Systematic review of anti-tumor necrosis factor-alpha therapy for treatment of immune-mediated uveitis
Q64226421Update in treatment of uveitic macular edema
Q52899661[Anti-TNF-α treatment for uveitis. Analysis of the current situation].

Search more.